Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch

reported from the source Quick summary: Novo Nordisk’s shares increased by over 8% following positive early prescription data for its new obesity pill, Wegovy, which launched on January 5. Shares of Novo Nordisk rose more than 8% on Friday after…







